AHL Partners’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-67,940
Closed -$2.05M 1366
2017
Q3
$2.05M Buy
67,940
+37,360
+122% +$1.11M 0.04% 664
2017
Q2
$899K Buy
30,580
+22,332
+271% +$610K 0.02% 805
2017
Q1
$209K Sell
8,248
-4,920
-37% -$127K ﹤0.01% 1150
2016
Q4
$338K Sell
13,168
-23,496
-64% -$617K 0.01% 943
2016
Q3
$1M Buy
36,664
+14,564
+66% +$400K 0.04% 599
2016
Q2
$623K Buy
22,100
+7,464
+51% +$192K 0.03% 560
2016
Q1
$346K Sell
14,636
-103,184
-88% -$2.27M 0.02% 640
2015
Q4
$2.65M Buy
117,820
+99,792
+554% +$2.28M 0.21% 178
2015
Q3
$417K Sell
18,028
-183,920
-91% -$4.61M 0.07% 442
2015
Q2
$4.97M Sell
201,948
-11,128
-5% -$278K 0.2% 181
2015
Q1
$5.34M Buy
213,076
+102,732
+93% +$2.44M 0.21% 149
2014
Q4
$2.55M Buy
110,344
+99,420
+910% +$2.28M 0.13% 334
2014
Q3
$255K Buy
+10,924
New +$256K 0.02% 636

Other funds holding TECH

AHL Partners's TECH Position: Q4 2017 in Review

AHL Partners sold out of Bio-Techne (TECH) in Q4 2017, closing a stake of 67,940 shares — an estimated $2.05M sold.

AHL Partners first reported a position in TECH in Q3 2014 and held it in 13 quarters. The position peaked at $5.34M in Q1 2015. 297 funds tracked by Wall St. Rank hold TECH as of Q4 2017.

  • AHL Partners reported no remaining Bio-Techne position as of Q4 2017 after selling out during the quarter.
  • AHL Partners sold 67,940 Bio-Techne shares in Q4 2017, an estimated $2.05M.
  • AHL Partners first reported a position in Bio-Techne in Q3 2014 and held it in 13 quarters.
  • AHL Partners's Bio-Techne position peaked at $5.34M in Q1 2015.
  • 297 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.